Pig liver machine tested as lifeline for patients in liver failure
NCT ID NCT07429838
Summary
This is a first-in-human safety study testing a new device that temporarily supports failing livers. The device connects a patient's blood to a genetically engineered pig liver, aiming to filter toxins and perform liver functions. The trial will enroll up to 20 adults with severe, sudden liver failure who are not currently eligible for a transplant, to see if the approach is safe and can help stabilize them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
Contact
-
Washington University
St Louis, Missouri, 63130, United States
Contact
Conditions
Explore the condition pages connected to this study.